Our new website is coming soon, give it a try now and let us have your feedback. Take me to the Beta



Register
Login:
Share:
Email Facebook Twitter


TSX Lithium explorer International Lithium Corp prepares to drill at Raleigh Lake
Exclusive: Hardman & Co Investor Forum - Severn Trent, Calculus Capital, Volta Finance, Residential




Share Price Information for Shield Thera (STX)


Share Price: 112.50Bid: 111.00Ask: 114.00Change: 0.00 (0.00%)No Movement on Shield Thera
Spread: 3.00Spread as %: 2.70%Open: 112.50High: 112.50Low: 112.50Yesterday’s Close: 112.50

Shield Therapeutics Plc Ord 1.5P






Share Price SpacerPrice
112.50
Share Price SpacerBid
111.00
Share Price SpacerAsk
114.00
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
880
Share Price SpacerOpen
112.50
Share Price SpacerHigh
112.50
Share Price SpacerLow
112.50
Share Price SpacerClose
112.50
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 117.09m £131.72m 2,000

52 Week High 122.50 52 Week High Date 29-MAY-2019
52 Week Low 29.00 52 Week Low Date 31-DEC-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
1 0 0 -56.250 -2.00 0.00 0.00


London South East Users info for Shield Thera




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

18-Jun-19
08:00:45
112.50
880
 
111.00
114.00
990.00
Trade Type:
Ordinary

17-Jun-19
17:08:21
112.50
1,620
 
0.00
0.00
1,823
Trade Type:
Ordinary

17-Jun-19
17:08:21
112.50
1,620
 
111.00
114.00
1,823
Trade Type:
Ordinary




View more Shield Thera trades >>

Directors Deals for Shield Thera (STX)
Trade DateActionNotifierPriceCurrencyAmountHolding
25-Apr-19Buy
Trade Notifier Information for Shield Therapeutics
Mark Sampson held the position of Chief Medical Officer at Shield Therapeutics at the time of this trade.
 Mark Sampson
90.7GBX22,04283701
16-Apr-19Buy
Trade Notifier Information for Shield Therapeutics
James M Karis held the position of Non-Executive Chairman at Shield Therapeutics at the time of this trade.
 James M Karis
81GBX4,00086667
16-Apr-19Exercise of option
Trade Notifier Information for Shield Therapeutics
Carl Sterritt held the position of CEO at Shield Therapeutics at the time of this trade.
 Carl Sterritt
1.5GBX123,69010198951
View more Shield Thera directors dealings >>


Jim-sparks
Posts: 31
Opinion:No Opinion
Price:113.50
Drop?
3 Jun '19
Was that Huge drop AM on the back of an appeal that we knew was coming?
Midastouch2015
Posts: 9
Opinion:No Opinion
Price:97.00
RE: Investors beware
3 Jun '19
its so true but again appeals are always filled automaticely
ShareSocUK
Posts: 282
Opinion:No Opinion
Price:112.50
Seminar Presentation
27 May '19
The Shield Therapeutics presentation from our London seminar on the 8th May are available for our full members to view here: https://sharesoc.ning.com/xn/detail/6389471:Comment:53127
GoldenDust
Posts: 16
Opinion:No Opinion
Price:115.00
RE: Investors beware
23 May '19
Never any guarantees. Not with Motif Bio (in which I was invested), not with Shield, and not with life in general. Saying so really is no more than stating the obvious.

However, one difference is that a knock-back for Shield from the FDA won't kill the company. Feraccru is approval in Europe with a wide indication and a favourable licensing deal, sales under way, milestone payments coming in and cash in the bank. If approval in the US isn't forthcoming, for whatever reason, it simply addresses the problem and goes again. And in the meantime gets on with business elsewhere.

So it is considerably de-risked in comparison with Motif bio, which might live to fight another day, but currently has no clarity from the FDA (last time I looked), is running on fumes, has no income, and a cash call is imminent.

Any new funds Motif is currently negotiating are likely to come at a valuation heavily discount against the current share price because the company has it's back to the wall. And without clarity from the FDA, it's a punt. And that would hit investors (who didn't see the same kind of rise ahead of the pdufa date that Shield is seeing) hard ... again.
View more share chat for Shield Thera (STX) >>







Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk











Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.